Awards
Glaucoma Research Foundation
yearly
50,000 $
For more than 40 years, Glaucoma Research Foundation has been the premiere organization in glaucoma research funding.
We support new high-impact clinical, epidemiological and laboratory research based on our strategic research goals.
Strategic Research Goals
- Protect and restore the optic nerve
- Accurately detect glaucoma and monitor its progress
- Find the genes responsible for glaucoma
- Understand the intraocular pressure system and develop better treatments
- Determine the risk factors for glaucoma damage using systematic outcomes data
Core Values
- Involve people with glaucoma in the design, implementation and evaluation of programs.
- Encourage collaboration among experts in many fields of study to achieve GRF goals.
- Communicate research goals and results to the scientific community and the public.
- Ensure that new glaucoma treatments maintain or improve individuals’ quality of life.
- Encourage innovative clinical trial studies and laboratory research.
- Develop cell and animal models of glaucoma to support research studies.
- Facilitate and support the development of physician-scientists to advance glaucoma research.
The online application is accepted annually from June 1 until July 15
Vergabeordnung:
https://www.glaucoma.org/research/applying-for-a-grant.phpKontakt:
Bisherige Preisträger:
2023
Benjamin J. Frankfort, MD, PhD, Baylor College of Medicine, für sein Projekt: „Adrenergic Receptor Function and Role in Neuroprotection“
Karsten Gronert, PhD an der University of California, Berkeley, für sein Projekt: „LXB4 Regulation of Microglia Homeostatic Function a Neuroprotective Target“
Wendy Liu, MD, PhD, an der Stanford University, für ihr Projekt: „Investigating Mechanosensitive Ion Channel Variants and their Role in Glaucoma“
Xiaorong Liu, PhD, University of Virginia, für ihr Projekt: „An In Vivo Biomarker to Monitor Glaucoma Progression“
Cezary Rydz, MD, an der University of California, Irvine, für sein Projekt: „Modulating Ocular Hypertension Induced Accelerated Aging in Rodent Retina“
James Tribble, PhD, am Karolinska Institutet in Stockholm, Schweden, für das Projekt: „Drug-driven Identification of Inflammatory Pathways in Retinal Microglia“
James Walsh, MD, PhD, Washington University in St. Louis, für sein Projekt: „Choroid Resident T Cells are Vital for Retinal Ganglion Cell Neuroprotection in Ocular Hypertensive Injury“
Benjamin Xu, MD, PhD , an der University of Southern California, für das Projekt: „In Vivo Ultrasound Elastography of Iris Stiffness in Angle Closure Glaucoma.“
2020:
Steven Bassnett, PhD; Washington University School of Medicine
Project: Role of LOXL1 Propeptide Aggregation in Pseudoexfoliation Glaucoma
Stewart Bloomfield, PhD; State University of New York College of Optometry
Project: Retinal Gap Junctions Form Novel Targets for Neuroprotective Therapy in Glaucoma
Alex Huang, MD, PhD; Doheny Eye Institute
Project: Investigating Subconjuctival Lymphatics for the Treatment of Glaucoma and Eye Disorders
Tatjana Jakobs, MD; Schepens Eye Research Institute
Project: The Transcription Factor Runx1 as a Novel Mediator of Astrocyte Reactivity in the Optic Nerve
Rachel Kuchtey, MD, PhD; Vanderbilt Eye Institute
Project: Investigation of Ocular Biomechanical Defects in Mice with Microfibril and Elastic Fiber Defects
Herbert Lachmann, MD; Albert Einstein College of Medicine
Project: Gene Expression Profiling in Trabecular Meshwork Cells derived from Induced Pluripotent Stem Cells made from Patients with Lowe Syndrome, a Genetic Disorder that causes Cataracts and Glaucoma
Matthew B. Veldman, PhD; Medical College of Wisconsin
Project: Zebrafish Retinal Ganglion Cell Survival in the Context of Pro-Apoptotic Bax Signaling
Trent A. Watkins, PhD; Baylor College of Medicine
Project: Highly Parallel Assessment of RGC Regenerative and Neuroprotective Targets
2019:
Steven Barnes, PhD; Project: Functional Resilience of Retinal Ganglion Cells During Mitochondrial Dysfunction
Adnan Dibas, PhD; Project: Endothelin Converting Enzyme Knockdown is Neuroprotective in Glaucomatous Neuropathy
Ankur Jain, PhD; Project: Autophagy-targeted Treatment for Myocilin-associated Glaucoma
Pierre Mattar, MSc, PhD; Project: Programming and Reprogramming for Retinal Ganglion Cell Replacement Therapy
Lauren Katie Wareham, PhD; Project: Investigating the Role of the NO-GC-1-cGMP Signaling Pathway in Glaucoma
Pete A. Williams, PhD; Project: Targeting Neuronal Mitochondria for Neuroprotection in Glaucoma